The Ministry of Health reports on Thursday a plan to expand the medical cannabis reform so that specialist physicians can approve medical cannabis for patients without criticism from the Ministry of Health and the Medical Cannabis Unit for patients with serious illnesses.
The intention is to approve the sale of medical cannabis in pharmacies in the registry specialized doctor For oncology patients, those with intestinal diseases, HIV and Parkinson's patients over the age of 18, who consume less than 40 per month, and children with epilepsy.
In fact, the details are almost identical to the medical cannabis reform, which will begin in the coming weeks with a slight upgrade. The Ministry of Health will soon publish public comments and draft regulations and then the details will be clearer.
Another important line is the expected release of the component CBD Of the Drugs Ordinance, similar to the bill submitted earlier this week. "Will exclude products that do not include THC (Such as products containing CBD only) from the Dangerous Drugs Ordinance, "it was reported.
According to this plan, the production and import of food supplements or preparations containing CBD alone, without THC, will also be possible. This component, cannabidiol, is a molecule with little psychoactive effect that is primarily a function of calmness and tranquility and is considered to have anti-inflammatory, anti-epileptic properties and more.
The decision to allow the use and trade of CBD products is a great news for the Israeli industry, and after that the Pharm chains are expected to be filled with CBD products, which will replace other tranquilizers, and according to Prof. Rafael Meshulam, a true drug for 1.
Deputy Health Minister Yaakov Litzman is a longstanding opponent of legalization and has declared at every stage that he will work hard to prevent legalization in Israel, and therefore it is certainly not a matter of cannabis removal from the drug command, as reported this evening by 12.
This error comes after a similar error from the beginning of the week, when reporter Daphna Liel reported that MK Sharan Hechel's bill from the Likud would remove the cannabis from the drug command, even though it was not a criminal offense.
Deputy Health Minister Yaakov Litzman said: "I have decided to adopt the position of professionals in the Health Ministry to allow a prescription instead of a license for certain medical conditions for which diagnosis is clear. I emphasize that this is not legalization and that a person who is not medically allowed to use it will not be able to receive the drug at the pharmacy. But this is a process that will make it easier for bureaucratic procedures to be made available to the sick public. "
"Israel is leading the use of cannabis for medical purposes," said Moshe Bar-Siman-Tov, director general of the Ministry of Health. "This step is another step in relieving patients and turning medical cannabis into a medical product like any other product. We will continue to monitor the application and make it easier for patients, while ensuring that those who need to receive receive the easiest way. "
Prof. Itamar Grotto, Deputy Director-General of the Ministry of Health, said: "The establishment of the Ministry of Health, which led to the existence of quality products and controlled throughout the manufacturing and conveying network, now allows for the condition that medical cannabis will be given to patients at pharmacies after they have been registered by a doctor Specialist in oncology, neurology, gastroenterology, and infectious diseases. In addition, production and importation of food supplements or preparations containing CBD alone will also be possible. We are confident that this will ensure the quality of the products and will improve the service for patients. "